AI-Powered Insights
Empowering Frontline Detection
OraLiva’s non-invasive brush biopsy delivers precise, AI-powered insights on oral cancer and dysplasia empowering dental providers to detect disease early and take action with confidence.
Reliable.
Clinically Validated.
AI-powered.
Sensitivity Clinically Validated
Validated in a Landmark NIH Study
How It Works
OraLiva collects a simple brush-biopsy sample with AI-powered cytology to deliver clinically-validated accuracy right in the hands of dental providers. Sample collection takes just minutes, fits seamlessly into a routine exam, and provides dentists with clear, data-driven results that support faster clinical decisions.
Brush Sample
Rapid Results
A digital report and numerical risk score arrive within days, empowering dentists to counsel patients immediately or refer to specialists when needed.
AI Analysis
Key Benefits for Dental Practices
OraLiva gives general dentists and DSOs a minimally-invasive, chairside way to detect oral cancer and dysplasia early. By adding AI-powered cytology to routine exams, practices improve patient outcomes and unlock new revenue without disrupting workflow.
- Enhanced patient comfort
- Improved clinical outcomes
- Revenue growth
Clinical Validation and
Proof
OraLiva’s accuracy is backed by peer-reviewed studies and a Phase II NIH SBIR grant, making it one of the most clinically validated oral-cancer screening tests available to dentists.
- Over 95%1 accuracy in multi-center clinical trials
- Peer-reviewed publications in leading journals
- 10 years of R&D across AI, engineering and science
How OraLiva Outperforms Existing Tests
There are several tools available for early oral-cancer detection, but not all offer the same level of accuracy, speed, or ease of use. This table provides a clear comparison between OraLiva’s AI-powered brush biopsy and other oral lesion adjunctive tests.
| Feature | OraLiva Brush Biopsy | Saliva Biomarker Tests | Fluorescence Tissue Imaging | Traditional Brush Biopsy | Sequencing-based Tests |
|---|---|---|---|---|---|
| < 1 week Turn-around Time |
|||||
| > 95% Accuracy | |||||
| Dental Reimbursement | |||||
| Early Disease Detection | |||||
| Benign Lesion Coverage | |||||
| Numerical Index Score | |||||
| Point-of-Care Capable |
Get Exclusive Early Access to the
Future of Oral Cancer Detection
See how OraLiva can improve outcomes, simplify workflow, and support earlier diagnosis, all from the chairside. Join our list to be the first to get updates.
Get exclusive early access.
Join OraLiva's Waitlist
